Why your standard blood test tells you so little

The results come back and the summary reads the same as last year: normal. And yet something feels off. Recovery after exercise takes longer than it used to. Energy dips arrive earlier in the day. Minor niggles linger. The panel says there is no disease — and that, it turns out, is almost all it was ever designed to say.

Standard NHS blood screening was built around a single, practical question: is something wrong enough to treat? That is a valuable question, but it is a different one from the question that matters most to anyone trying to hold on to vitality through their forties, fifties, and beyond: is my internal environment actually supporting repair?

Those two questions do not share an answer. A result that sits within the reference range may still reflect a biochemical climate in which the body's repair systems — stem cells, growth signals, immune clean-up crews, collagen synthesis — are quietly underperforming. 'Normal' describes a population average, not an optimised repair state.

In Regeneration by Design, Professor Paul Lee frames the Chemistry pillar around precisely this idea: blood is the medium through which cells receive the signals that tell them whether to repair or to decline. The Regen PhD Biomarker Panel — 32 markers across six biological systems — was built to answer the repair question, not the disease question. Four of those markers, in particular, tell you most of what you need to know.

This article is for general health-optimisation purposes only. It is not medical advice. If you have clinical concerns, please consult a qualified healthcare professional.

What blood chemistry is actually doing inside you

Think of blood not as a river carrying cargo from A to B, but as a living message board — one whose content shifts hourly in response to what you eat, how you move, how well you slept, and how much accumulated stress your tissues are carrying. Every cell it reaches reads that board before committing resources to repair or conserving them for another day.

Three inputs disrupt that signalling environment most reliably. Chronic low-grade inflammation floods the board with alarm messages that drown out repair cues — often years before any symptom surfaces. Glycaemic stress, driven by persistently elevated blood sugar, attaches sugar molecules to proteins through a process called glycation, degrading the structural precision that repair pathways depend on. And under-nutrition — particularly insufficient protein — depletes both the raw materials and the signalling molecules that cells need to act on repair instructions even when those instructions arrive correctly.

Tracking these inputs through specific blood markers lets you read the message board directly. That is the core logic behind the Regen PhD Biomarker Panel: not a screen for disease, but an audit of the repair environment — asking whether chemistry is working for the body's restoration systems or quietly working against them.

The field is moving toward even greater specificity. Collagen X (CXM), a protein that enters the bloodstream specifically during active bone repair, is near-undetectable in healthy resting tissue — a glimpse at mechanism-level, tissue-specific monitoring. That precision is still emerging; the four markers explored in this article represent what the evidence supports acting on now.

The four markers — and what each one is really measuring

hs-CRP: the fire alarm for silent inflammation

High-sensitivity C-reactive protein is produced by the liver in response to interleukin-6 released by activated macrophages and T cells — a direct measure of how much inflammatory noise is currently overriding the body's repair signals. The longevity-optimisation target is below 1.0 mg/L (ideally below 0.5 mg/L). Above 3.0 mg/L, the picture shifts into what researchers term 'inflammaging': the chronic low-grade inflammatory state associated with accelerated tissue decay. A 2022 cohort of 2,206 adults aged 80 and above (median age 93) found those in the highest hs-CRP quartile carried 49% greater all-cause mortality risk than those in the lowest (HR 1.49, 95% CI 1.20–1.87). Crucially, the marker is responsive: dietary patterns alone exert a measurable moderating effect on hs-CRP concentration, which means movement on this number is achievable.

IGF-1: the anabolic repair axis

Somatomedin C (IGF-1) is the primary adult output of the growth hormone axis. It activates PI3K/Akt and MAPK/ERK repair cascades, promoting cellular proliferation, suppressing programmed cell death, and sustaining the microcirculation that delivers nutrients to healing tissue. Its longevity role is genuinely dual: adequate levels support muscle maintenance and recovery; chronically excessive levels may paradoxically accelerate ageing pathways rather than slow them. Levels decline naturally across the decades, and the wellness objective is confirming the repair axis is adequately fuelled — somewhere in the healthy mid-range for one's age and sex — not chasing maximum output. No single published cut-off applies across all adults; this is precisely why reviewing IGF-1 within a physician-read panel, benchmarked to age- and sex-matched norms, matters more than comparing a result to any fixed absolute figure.

HbA1c: the two-month glycation record

Glycated haemoglobin captures average blood glucose over the preceding two to three months — a cumulative tally of the sugar-protein bonding occurring throughout vessels, tendons, and connective tissue. These advanced glycation end-products (AGEs) stiffen and degrade the structural fabric that repair pathways depend upon. Below 5.4% (36 mmol/mol) is the longevity benchmark; the 5.7–6.4% window signals pre-diabetes territory, where glycation-driven tissue and vascular damage measurably accelerates biological ageing.

Albumin: protein reserve and inflammatory burden in one number

The liver synthesises albumin as its principal circulating protein — and the same chronic inflammation that drives hs-CRP upward tends to suppress albumin production simultaneously. In a study of 2,780 elderly patients, a CRP-to-albumin ratio above 8 was independently associated with a more than ten-fold increase in 7-day mortality risk (AUC 0.888), illustrating that these two markers function as a compound, paired signal rather than independent readings. Beyond the inflammatory link, albumin reflects nutritional protein reserve and liver synthetic capacity; age-related decline has been linked to compromised vascular barriers in the brain and eyes, with downstream effects on mitochondrial function and oxygenation.

Standard NHS panels routinely omit hs-CRP at high sensitivity, along with HOMA-IR and ApoB. The Regen PhD Biomarker Panel includes all three — because the Chemistry pillar's starting point is an accurate read of the repair environment, not a threshold for clinical intervention.

Why these four markers form a system, not a checklist

Four numbers on a lab report look like four separate facts. In the body, they are anything but.

Sustained high hs-CRP actively suppresses the liver's albumin synthesis — during an inflammatory state, the liver redirects protein resources toward acute-phase reactants, so albumin production falls as hs-CRP climbs. That same inflammatory load blunts the growth hormone axis, reducing IGF-1 output and the cellular repair signalling it carries. And chronically elevated blood glucose, recorded months later in HbA1c, stiffens vessel walls through AGE formation, which amplifies local inflammatory pressure — feeding back into hs-CRP. Causality here runs in loops, not lines.

The CRP-to-albumin relationship, discussed in the previous section, is the sharpest illustration of this coupling: the ratio carries substantially more predictive weight than either value in isolation precisely because the two proteins are biologically yoked. When systemic inflammation rises, albumin falls — the gap between them widening as the repair environment deteriorates.

Reading all four markers together, then, gives a direction of travel rather than a static snapshot. When hs-CRP sits below 1.0 mg/L, albumin is stable, HbA1c is below 5.4%, and IGF-1 falls within a healthy mid-range for age and sex, the internal signalling environment is broadly permissive for restoration. When inflammation climbs while albumin and IGF-1 drift downward and HbA1c creeps upward, the chemistry is working against the body's own repair machinery — even if no individual value has yet crossed a clinical threshold.

Professor Paul Lee's argument in Regeneration by Design is that the Chemistry pillar cannot be tuned in isolation. The upstream inputs that move these four numbers — movement load, sleep quality, dietary pattern, stress accumulation — belong to all four pillars simultaneously. The markers do not cause each other in a vacuum; they reflect the same converging or diverging conditions. That is why a checklist of four results misses the point, and a system-level reading does not.

What longevity-optimal ranges actually look like

Standard reference ranges are not targets — they are statistical constructs, derived from large population samples and calibrated to catch disease before it becomes an emergency. Falling inside the band tells you that you are not yet a clinical outlier. It says nothing about whether your internal environment is actively supporting repair.

The gap between those two things is the crux. For hs-CRP, the typical clinical alarm threshold sits an order of magnitude above the longevity-medicine optimisation target given in the previous section — meaning most adults who are flagged 'normal' are still carrying meaningful inflammatory load by optimisation standards. HbA1c shows a similar pattern: the pre-diabetes warning sits well above the level at which glycation-driven tissue wear begins to meaningfully accumulate. For albumin, the conventional concern is frank deficiency; longevity-oriented practice looks for values in the upper-normal range as a positive signal of protein reserve and liver synthetic capacity, not merely 'not low enough to worry about'.

IGF-1 is the exception that resists a single benchmark entirely. Because both depletion and excess carry risk, and because the hormone's natural range shifts substantially with age and sex, the working target is mid-normal for your own demographic cohort — a relative call that depends on context rather than a fixed absolute figure.

These are wellness-optimisation benchmarks drawn from longevity-medicine practice and the Regen PhD clinical panel, not diagnostic cutoffs. Anyone reviewing their results should discuss them with a healthcare professional before drawing conclusions or making changes.

Turning your blood chemistry into a repair plan

Getting tested is the practical starting point. The Regen PhD Biomarker Panel — 32 markers drawn at Harley Street and reviewed by a physician within five days — is built around these four signals alongside the broader inflammatory, metabolic and hormonal picture. Private providers such as Medichecks offer longevity-oriented panels that cover the same core markers. Standard NHS screens often omit hs-CRP entirely; patients who want it typically need to request it specifically from their GP.

Once the numbers are in hand, the aim is to treat them as a baseline, not a verdict. All four markers are responsive to lifestyle inputs — they shift when conditions shift. hs-CRP and albumin track anti-inflammatory dietary patterns and protein adequacy. HbA1c responds to reduced refined carbohydrate load and improved glucose tolerance. IGF-1 moves with resistance training and protein timing. None of these is fixed by the result on a single print-out.

Progress becomes visible through re-testing — ideally every three to six months at first, then annually once a stable pattern is established. This is the Time pillar made concrete: repair status is not a single data point but a direction of travel across months.

The deeper payoff comes when Chemistry is addressed alongside the other pillars. In Regeneration by Design, Professor Paul Lee's central argument is that repair is engineered, not accidental — and the engineering happens across Physics (movement and load), Biology (sleep and gut function) and Chemistry simultaneously. Better sleep reduces inflammatory pressure; adding resistance training lifts IGF-1; both move the numbers. The blood panel measures the result of the whole system, which is reason enough to discuss any persistently out-of-range findings with a healthcare professional before acting on them.